Pomalidomide-PEG4-C2-NH2

Background Introduction

Pomalidomide-PEG4-C2-NH2 is a versatile E3 ligase ligand-linker conjugate widely used in the development of PROTACs (Proteolysis Targeting Chimeras). This bifunctional molecule harnesses pomalidomide, a high-affinity cereblon (CRBN) ligand, connected to a reactive amine terminus via a polyethylene glycol (PEG4) spacer and a two-carbon linker. Its rationally designed structure supports the modular assembly of heterobifunctional degraders for targeted protein degradation, facilitating innovative solutions in chemical biology and drug discovery.

Mechanism

The mechanism of Pomalidomide-PEG4-C2-NH2 relies on its ability to recruit the cereblon (CRBN) E3 ubiquitin ligase complex via the pomalidomide moiety. The conjugate's linker (PEG4-C2-NH2) provides both spacing and functional flexibility, enabling attachment to various ligands specific to proteins of interest. Once incorporated into a PROTAC molecule, this bifunctional agent simultaneously binds the target protein and CRBN, forming a ternary complex. This proximity-induced interaction promotes ubiquitination of the target protein, marking it for degradation by the ubiquitin-proteasome system.

Applications

Pomalidomide-PEG4-C2-NH2 finds broad applications in the synthesis of next-generation PROTACs and molecular glues for targeted protein degradation. Researchers leverage this ligand-linker conjugate to develop customized degraders against disease-relevant proteins, particularly in cancer, neurodegenerative diseases, and immunology. Its PEGylated linker enhances solubility and pharmacokinetic properties, proving valuable in both in vitro screening of PROTAC candidates and in vivo preclinical research. The reactive amine tail allows straightforward conjugation to diverse targeting ligands, supporting the rapid prototyping of novel E3 ligase-recruiting molecules tailored for therapeutic or mechanistic studies.

• Improved aqueous solubility and flexibility due to PEG4 linker, facilitating efficient PROTAC assembly.
• Amine-functionalized terminus enables versatile coupling strategies for streamlined CRBN E3 ligase-based PROTAC synthesis.

The Pomalidomide-PEG4-C2-NH2 E3 Ligase Ligand-Linker Conjugate plays a crucial role in the development of PROTACs by facilitating targeted protein degradation. It offers flexibility and specificity, enhancing the efficacy of protein degradation processes. The following provides a detailed description of this molecule, focusing on the linker, ligand, and selection of target protein ligands.

Linker: The PEG4-C2 linker in this molecule is characterized by its medium length and flexible nature, which allows for optimal spatial arrangement between the ligand and the target protein. Its non-cleavable design ensures stability throughout the degradation process, maintaining the integrity of the conjugate.

Ligand: The ligand component, pomalidomide, is a thalidomide derivative known for its effective E3 ligase recruitment. Its structural characteristics include an imide group that is essential for binding to the cereblon E3 ligase, facilitating targeted protein ubiquitination and subsequent degradation.

Reactive Site: The reactive site in this molecule is the terminal amine group, which couples efficiently with electrophilic groups on the target protein ligand. Recommended reaction types for this coupling include amide bond formation or reductive amination, providing robust and stable linkages.

Recommended Target Protein Ligand: The ideal warhead for use with this conjugate is an electrophilic moiety, such as an acrylamide or chloroacetamide, which can form covalent bonds with cysteine residues on the target protein. This approach enhances target specificity and potency, making it suitable for applications in studying protein function and validating therapeutic targets in cellular models.